Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts-Reference-Cited by-同舟云学术

Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts

Published:2019-02-12 Issue:5 Volume:94 Page:512-521
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Zhao Xiao‐Su¹²^ORCID,Liu Yan‐Rong¹,Xu Lan‐Ping¹,Wang Yu¹²,Zhang Xiao‐Hui¹²^ORCID,Chen Huan¹,Chen Yu‐Hong¹,Han Wei¹,Sun Yu‐Qian¹,Yan Chen‐Hua¹,Mo Xiao‐Dong¹^ORCID,Wang Ya‐Zhe¹,Fan Qiao‐Zhen¹,Wang Xin‐Yu¹,Liu Kai‐Yan¹^ORCID,Huang Xiao‐Jun¹³^ORCID,Chang Ying‐Jun¹³^ORCID

Affiliation:

1. Peking University People's Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell TransplantationPeking University People's Hospital & Peking University Institute of Hematology Beijing China

2. Peking‐Tsinghua Center for Life Sciences Beijing China

3. Collaborative Innovation Center of HematologyPeking University Beijing China

Funder

Beijing Municipal Science and Technology Commission

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25417

Reference61 articles.